151 related articles for article (PubMed ID: 34973391)
21. Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer.
Jiang T; Tang HM; Lu S; Yan DW; Yang YX; Peng ZH
Med Oncol; 2013 Dec; 30(4):715. PubMed ID: 24078150
[TBL] [Abstract][Full Text] [Related]
22. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D-Binding Protein Enhances Epithelial Ovarian Cancer Progression by Regulating the Insulin-like Growth Factor-1/Akt Pathway and Vitamin D Receptor Transcription.
Huang YF; Wu YH; Cheng WF; Peng SL; Shen WL; Chou CY
Clin Cancer Res; 2018 Jul; 24(13):3217-3228. PubMed ID: 29476020
[No Abstract] [Full Text] [Related]
24. TRIM29 as a novel biomarker in pancreatic adenocarcinoma.
Sun H; Dai X; Han B
Dis Markers; 2014; 2014():317817. PubMed ID: 24864129
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
27. TRIM29 suppresses TWIST1 and invasive breast cancer behavior.
Ai L; Kim WJ; Alpay M; Tang M; Pardo CE; Hatakeyama S; May WS; Kladde MP; Heldermon CD; Siegel EM; Brown KD
Cancer Res; 2014 Sep; 74(17):4875-87. PubMed ID: 24950909
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis.
Saddoughi SA; Gencer S; Peterson YK; Ward KE; Mukhopadhyay A; Oaks J; Bielawski J; Szulc ZM; Thomas RJ; Selvam SP; Senkal CE; Garrett-Mayer E; De Palma RM; Fedarovich D; Liu A; Habib AA; Stahelin RV; Perrotti D; Ogretmen B
EMBO Mol Med; 2013 Jan; 5(1):105-21. PubMed ID: 23180565
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis.
Hu X; Garcia C; Fazli L; Gleave M; Vitek MP; Jansen M; Christensen D; Mulholland DJ
Sci Rep; 2015 Nov; 5():15182. PubMed ID: 26563471
[TBL] [Abstract][Full Text] [Related]
30. E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1.
Deng X; Fu X; Teng H; Fang L; Liang B; Zeng R; Chen L; Zou Y
J Transl Med; 2021 Aug; 19(1):332. PubMed ID: 34353343
[TBL] [Abstract][Full Text] [Related]
31. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
32. SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.
Inoue D; Kitaura J; Matsui H; Hou HA; Chou WC; Nagamachi A; Kawabata KC; Togami K; Nagase R; Horikawa S; Saika M; Micol JB; Hayashi Y; Harada Y; Harada H; Inaba T; Tien HF; Abdel-Wahab O; Kitamura T
Leukemia; 2015 Apr; 29(4):847-57. PubMed ID: 25306901
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.
Cristóbal I; Caramés C; Rincón R; Manso R; Madoz-Gúrpide J; Torrejón B; González-Alonso P; Rojo F; García-Foncillas J
Oncotarget; 2017 Jun; 8(25):40169-40180. PubMed ID: 27517624
[TBL] [Abstract][Full Text] [Related]
34. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
[TBL] [Abstract][Full Text] [Related]
35. TRIM29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of E-cadherin.
Xu W; Chen B; Ke D; Chen X
Aging (Albany NY); 2020 Jul; 12(13):13488-13501. PubMed ID: 32640423
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET.
Arnaud L; Chen S; Liu F; Li B; Khatoon S; Grundke-Iqbal I; Iqbal K
FEBS Lett; 2011 Sep; 585(17):2653-9. PubMed ID: 21806989
[TBL] [Abstract][Full Text] [Related]
37. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
38. Arsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.
Tian Y; Liu Y; He P; Liu F; Zhou N; Cheng X; Shi L; Zhu H; Zhao J; Wang Y; Zhang M
PLoS One; 2014; 9(1):e83184. PubMed ID: 24454695
[TBL] [Abstract][Full Text] [Related]
39. Significance of TRIM29 and β-catenin expression in non-small-cell lung cancer.
Zhou ZY; Yang GY; Zhou J; Yu MH
J Chin Med Assoc; 2012 Jun; 75(6):269-74. PubMed ID: 22721621
[TBL] [Abstract][Full Text] [Related]
40. TRIM29 negatively regulates p53 via inhibition of Tip60.
Sho T; Tsukiyama T; Sato T; Kondo T; Cheng J; Saku T; Asaka M; Hatakeyama S
Biochim Biophys Acta; 2011 Jun; 1813(6):1245-53. PubMed ID: 21463657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]